KRAS and lung cancer: By 8 weeks resistant lung cancer nodules develop which are FDG avid, but these resistant nodules are not adenocarcinoma (the classic histological subtype of human STK11-deficient/KRAS mutant lung cancer) but squamous cell carcinoma.